ALERT Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, UNIT Shareholders are Encouraged to Contact the Firm
RPHMDelisted Stock | USD 18.20 1.40 8.33% |
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Reneo |
NEW YORK, May 29, 2024 -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws andor breaches of fiduciary
Read at benzinga.com
Reneo Pharmaceuticals Fundamental Analysis
We analyze Reneo Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reneo Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reneo Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Reneo Pharmaceuticals is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Reneo Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reneo Pharmaceuticals Related Equities
CNSP | Cns Pharmaceuticals | 10.00 | ||||
DNA | Ginkgo Bioworks | 9.07 | ||||
PRME | Prime Medicine, | 6.52 | ||||
CGEM | Cullinan Oncology | 5.13 | ||||
CELC | Celcuity LLC | 4.39 | ||||
KZR | Kezar Life | 4.27 | ||||
CCCC | C4 Therapeutics | 3.36 | ||||
HOWL | Werewolf Therapeutics | 3.25 | ||||
NKTX | Nkarta | 2.98 | ||||
HEPA | Hepion Pharmaceuticals | 2.04 | ||||
SMMT | Summit Therapeutics | 1.77 | ||||
ADPT | Adaptive Biotechnologies | 0.78 | ||||
VIR | Vir Biotechnology | 0.27 | ||||
EWTX | Edgewise Therapeutics | 0.14 | ||||
RPRX | Royalty Pharma | 0.08 | ||||
KRON | Kronos Bio | 1.04 | ||||
APLS | Apellis Pharmaceuticals | 1.08 | ||||
LEGN | Legend Biotech | 3.33 | ||||
IMMX | Immix Biopharma | 3.67 | ||||
OCEA | Ocean Biomedical | 5.08 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |